ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Clarifies Plan For Review Of Epidemiologic Research

June 1, 2001

DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components

May 16, 1986

ACS Goal To Raise Percentage Of Women Who Get Mammograms

July 31, 1992

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009